Skip to main content
. 2023 Mar 27;9(1):1–7. doi: 10.1016/j.afos.2023.03.008

Fig. 3.

Fig. 3

The clinical interventions pertaining to activators and inhibitors of myostatin. The figure illustrates different therapeutic interventions, which are currently being worked upon to regulate activation and inhibition of myostatin and finetune sarcomeric protein synthesis and degradation.